| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.0004 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.17 | 0.0008 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.0008 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.14 | 0.001 |